-
-
Overview
-
Sulfamethizole is a broad-spectrum sulfathiazole antibacterial of the Sulfonamide class, used for the bacteria causing urinary tract infections. Acting as a synthetic analog of para-aminobenzoic acid (PABA), it competitively inhibits this compound, which is a substrate of dihydropteroate synthetase in the folic acid pathway. It is also a mammalian target of rapamycin (mTOR) inhibitor.
Please contact us at for specific academic pricing.
Background
Sulfamethizole interferes with bacterial folic acid production, inhibiting a substrate of dihydropteroate synthetase named para-aminobenzoic acid (PABA). Thus, PABA is not incorporated into dihydrofolic acid, the immediate precursor to folic acid. This results in cell growth arrest and death. Other mechanisms affecting the folic acid pathway may be involved, as only only microorganisms that make their own folic acid are inhibited by sulfonamides. Animal cells and bacteria that can use folic acid precursors or preformed folic acid are not affected by sulfonamides. Sulfamethizole is also a mammalian target of rapamycin (mTOR) inhibitor, and this property was shown with homology modeling and verified via in vitro screening (Khanfar et al, 2013).
-
- Properties
- Applications
-
Overview